EX-10.2
from 10-Q
77 pages
Certain Confidential Information Contained in This Document, Marked by [*], Has Been Omitted Because It Is Not Material and Would Likely Cause Competitive Harm to Day One Biopharmaceuticals, Inc. if Publicly Disclosed. Exclusive License Agreement by and Between Mabcare Therapeutics (上海麦科思生物医药有限公司) and Day One Biopharmaceuticals, Inc. June 17, 2024
12/34/56
EX-10.9
from S-1/A
7 pages
Re: Day One Biopharmaceuticals, Inc. – Employment Offer Dear Jeremy, Pursuant to Our Recent Discussions, I Am Pleased to Send You, on Behalf of Day One Biopharmaceuticals, Inc. (The “Company”), This Letter Agreement (The “Agreement”) Which Sets Forth the Terms of an Offer for Employment With the Company. 1. Position. Duties and Conditions Precedent
12/34/56
EX-10.4
from S-1
55 pages
Certain Confidential Information Contained in This Document, Marked by [*], Has Been Omitted Because It Is Not Material and Is the Type That the Registrant Treats as Private and Confidential. Oyster Point Marina Plaza Office Lease of Suite 217 to Day One Therapeutics, Inc., a Delaware Corporation 395 Oyster Point Boulevard South San Francisco, Ca 94080 Oyster Point Marina Plaza Office Lease
12/34/56